Galapagos Nv Is A Belgian Biotechnology Company Founded In 1999Headquartered In Mechelenbelgiumwith Additional Locations In Several European Cities And Bostonthe Company Is Publicly Traded On Euronext Amsterdambrusselsand Nasdaq Under The Ticker Symbol Glpggalapagos Is Dedicated To Improving Patient Outcomes Through Scientific Innovationparticularly In Oncology And Immunology The Company Focuses On Drug Developmentwith A Robust Pipeline That Includes Small Moleculescar T Therapiesand Biologicsnotable Products Include Filgotiniba Jak1 Inhibitor For Rheumatoid Arthritisand Several Car T Therapies Targeting Cancers Such As Non Hodgkin Lymphoma And Multiple Myelomagalapagos Collaborates With Major Pharmaceutical Companies Like Gilead Sciences And Abbvie To Advance Its Research And Expand Its Impact In The Biotechnology Sectorthrough Its Commitment To Addressing High Unmet Medical Needsgalapagos Aims To Enhance The Quality Of Life For Patients
No conferences found for this company.
| Company Name | Galapagos Sasu |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
